Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sariya Udayachalerm, Maranda G. Renouard, Thunyarat Anothaisintawee, Ammarin Thakkinstian, Sajesh K. Veettil & Nathorn Chaiyakunapruk. (2022) Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence. Journal of Medical Economics 25:1, pages 26-37.
Read now
Read now
Patricia R. Blank, Zanfina Ademi, Xiaoyan Lu, Thomas D. Szucs & Matthias Schwenkglenks. (2017) Herpes zoster vaccine: A health economic evaluation for Switzerland. Human Vaccines & Immunotherapeutics 13:7, pages 1495-1504.
Read now
Read now
Sara Boccalini, Cristiano Alicino, Domenico Martinelli, Angela Bechini, Emilia Tiscione, Barbara Pellizzari, Rosa Prato, Giancarlo Icardi, Stefania Iannazzo & Paolo Bonanni. (2017) Clinical and economic impact of herpes zoster vaccination in elderly in Italy. Human Vaccines & Immunotherapeutics 13:2, pages 405-411.
Read now
Read now
Juan Luis Lopez-Belmonte, Ramón Cisterna, Angel Gil de Miguel, Caroline Guilmet, Florence Bianic & Mathieu Uhart. (2016) The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older. Journal of Medical Economics 19:6, pages 576-586.
Read now
Read now
Articles from other publishers (7)
Julie Bigay, Roger Le Grand, Frédéric Martinon & Pauline Maisonnasse. (2022) Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Frontiers in Microbiology 13.
Crossref
Crossref
Pierre-Olivier Lang & Richard Aspinall. (2019) Vaccination for quality of life: herpes–zoster vaccines. Aging Clinical and Experimental Research 33:4, pages 1113-1122.
Crossref
Crossref
Edward T. Chiyaka, Van T. Nghiem, Lu Zhang, Abhishek Deshpande, Patricia Dolan Mullen & Phuc Le. (2018) Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. PharmacoEconomics 37:2, pages 169-200.
Crossref
Crossref
Joke Bilcke, Frederik Verelst & Philippe Beutels. (2018) Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination. Medical Decision Making 38:6, pages 730-745.
Crossref
Crossref
Shu-ling Hoshi, Masahide Kondo & Ichiro Okubo. (2017) Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine 35:24, pages 3264-3271.
Crossref
Crossref
Gillian M. Keating. (2016) Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. BioDrugs 30:3, pages 243-254.
Crossref
Crossref
Nabila Ferahta, Imene Achek, Julie Dubourg & Pierre-Olivier Lang. (2016) Les vaccins contre le zona : efficacité, sécurité, et rapport coût/bénéfices. La Presse Médicale 45:2, pages 162-176.
Crossref
Crossref